242 related articles for article (PubMed ID: 15946488)
1. [Changes of visual field and visual evoked potential in nasopharyngeal carcinoma patients after radiotherapy].
Pan Y; Hu WH; Gao Y; Yu MZ; Huang SZ
Ai Zheng; 2005 Jun; 24(6):722-6. PubMed ID: 15946488
[TBL] [Abstract][Full Text] [Related]
2. [Change in visual evoked potential by radiotherapy of nasopharyngeal carcinoma].
Hu W; Yu M; Long S; Huang S; Gu M; Zhou L; Wu D
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):147-50. PubMed ID: 12015036
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effects of radiotherapy to the chiasm and optic nerve by visual psychophysical and electrophysiologic tests in nasopharyngeal carcinoma.
Esassolak M; Karagöz U; Yalman D; Köse S; Anacak Y; Haydaroğlu A
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1141-6. PubMed ID: 15001256
[TBL] [Abstract][Full Text] [Related]
4. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
5. Lhermitte's sign among nasopharyngeal cancer patients after radiotherapy.
Leung WM; Tsang NM; Chang FT; Lo CJ
Head Neck; 2005 Mar; 27(3):187-94. PubMed ID: 15627248
[TBL] [Abstract][Full Text] [Related]
6. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
[TBL] [Abstract][Full Text] [Related]
7. [Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma].
Xie GF; Cao KJ; Li Y; Huang PY
Ai Zheng; 2005 Oct; 24(10):1246-8. PubMed ID: 16219141
[TBL] [Abstract][Full Text] [Related]
8. [Radial optic neurotomy for ischemic central retinal vein occlusion].
Lommatzsch A; Heimes B; Gutfleisch M; Spital G; Trieschmann M; Pauleikhoff D
Klin Monbl Augenheilkd; 2007 Oct; 224(10):763-9. PubMed ID: 17952819
[TBL] [Abstract][Full Text] [Related]
9. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of radiation optic neuropathy].
Liu JL
Zhonghua Yan Ke Za Zhi; 1992 Mar; 28(2):86-8. PubMed ID: 1425040
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
[TBL] [Abstract][Full Text] [Related]
12. [Prospective study on long-term efficacy of external plus intracavitary radiotherapy on stage I-II nasopharyngeal carcinoma].
Cao XP; Lu TX; Ye WJ; Cui NJ
Ai Zheng; 2007 Feb; 26(2):204-7. PubMed ID: 17298754
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study on optic neuropathy and retinopathy subsequent to radiotherapy of nasopharyngeal carcinoma].
Zhou P; Wang SF; Miao CH
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):616-20. PubMed ID: 14766077
[TBL] [Abstract][Full Text] [Related]
14. [Long-term efficacy of radiotherapy on children with nasopharyngeal carcinoma].
Cao KJ; Li Y; Huang PY; Xie GF; Huang TB; Hong MH
Ai Zheng; 2004 Nov; 23(11):1322-4. PubMed ID: 15522182
[TBL] [Abstract][Full Text] [Related]
15. Impairment of optic path due to radiotherapy for nasopharyngeal carcinoma.
Hu WH; Yu MZ; Long SX; Huang SZ; Gu MF; Zhou LS; Wu DZ
Doc Ophthalmol; 2003 Sep; 107(2):101-10. PubMed ID: 14661899
[TBL] [Abstract][Full Text] [Related]
16. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
[TBL] [Abstract][Full Text] [Related]
17. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
19. Etiological analysis of the sequelae of radiotherapy for nasopharyngeal carcinoma: a follow-up study of 112 cases.
Yan WP; Chen LH; Xu ZX; Deng XG
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1002-5. PubMed ID: 14559677
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of radiotherapy combined with Traditional Chinese medicine (TCM) in NPC patients].
Yuan J; Zhang Z; Xiao JY
Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):254-6. PubMed ID: 12212157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
